Rheumatoid arthritis

Stratified distribution of Th17 and Treg cells in patients with multi-stage rheumatoid arthritis

Arthritis Res TherPublished Cross-sectional study

Authors' conclusion

The immune characteristics of Ea-RA patients differ from those of HCs; an immune system disorder is apparent although no differences in Th17 and Treg levels were evident between Ea-RA patients and HCs. We found distributional heterogeneities of Th17 and Treg cells in patients with multi-stage of RA.

Study context

Population
Patients with rheumatoid arthritis (RA) at different disease stages (early, advanced, treated) and healthy controls
Participants
131 / 117 / 109 / 97
Exposure
Early, advanced and treated RA vs healthy controls
  • Early RA (Ea-RA)n = 131
  • Advanced RA (Ad-RA)n = 117
  • Treated RA (Tr-RA)n = 109
  • Healthy controls (HCs)n = 97reference
Outcome
Peripheral blood lymphocyte subsets, particularly CD4+ T subsets (Th17 and Treg cells)
Methodological detailsflow cytometry, k-means clustering
  • Flow cytometry
  • K-means clustering

Main finding

As reported in the abstract

Peripheral blood lymphocyte subsets
  • Decreased absolute NK cell numbers and increased CD4/CD8 T cell ratios in different RA groups, including Ea-RA, vs HCs
  • Th17 and Treg cell numbers in Ea-RA similar to those in HCs
  • K-means clustering on Th17 and Treg profiles identified three patient types: A (relatively low Treg and Th17), B (moderate Treg; Th17 similar to type C), C (high Treg; Th17 similar to type B)

Observational data: associations, not effects.

Original publication

Stratified distribution of Th17 and Treg cells in patients with multi-stage rheumatoid arthritis. Arthritis Res Ther. Published 4 April 2023. doi:10.1186/s13075-023-03041-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.